Segmentation by types of service delineates the functional breadth of the Medical Device Testing, Inspection, and Certification market. Performance testing validates core device functionality, encompassing mechanical strength, fluid dynamics, and accuracy metrics, and is essential across all device categories. Biocompatibility testing, a regulatory prerequisite for implantable and therapeutic devices, evaluates cytotoxicity, sensitization, and systemic toxicity, directly influencing market share for high‑risk products. Electrical safety testing, including leakage current and electromagnetic compatibility, safeguards therapeutic and monitoring devices, contributing significantly to compliance costs. Software validation, increasingly critical for connected and AI‑enabled devices, assesses algorithmic integrity, cybersecurity, and user interface reliability. Finally, regulatory compliance certification—spanning FDA 510(k), CE marking, and ISO 13485 audits—provides market entry authorization and is a revenue driver for service providers. Each type addresses a specific risk domain, and their combined adoption rates determine the overall market magnitude, with performance and regulatory certification representing the largest revenue streams.